Marka sorgulama · Bülten 377

ai-powr

HEPİON PHARMACEUTİCALS, INC.

Tescilli Başvuru no 2021/092451 · 29 Aralık 2020 · vekilsiz başvuru

Süreç

  1. Başvuru 29 Aralık 2020
  2. Bültende yayın Resmî Marka Bülteni 377 · 27 Temmuz 2021
  3. İtiraz penceresi (2 ay) Son gün 27 Eylül 2021 · kapandı
  4. Tescil Tescil no 2021 092451· Gazete 474 (30 Kasım 2021)
  5. Yenileme Koruma 10 yıl: yenileme tarihi Aralık 2030 (son 6 ay içinde başvurulur).

Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.

Bu marka senin mi? Benzer bir başvuru bültene düştüğü gün e-posta alırsın; ilk marka ücretsiz. Web'de ya da uygulamada.

Sınıflar ve kapsam

Mal ve hizmet listesi

Computer software for using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field; computer software for integrating artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation with disease studies and investigations, pharmaceutical and drug research and development, biomedical, biological, and biotechnological research and development, and pharmacology, clinical pharmacology, system pharmacology, and system biology; computer software for clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; computer software for patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; computer software for drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, accessing, processing , and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, accessing, processing, and analyzing public and proprietary omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data via a global computer network using artificial intelligence, machine learning, supervised machine learni … (liste kısaltıldı; tamamı TÜRKPATENT kaydında)

Aynı bültende benzer başvurular

Bülten 377 içindeki 744 aynı-sınıf başvuru tarandı; 1 benzer bulundu.

  • p••• Yüksek benzerlik 1 6 9 20 41

İsimler uygulamada, Nomist Pro ile görünür.